Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum: Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study.

Hepatology (Baltimore, Md.)·2026
Same author

Utilizing group-based models to identify adverse event patterns after an intervention.

Frontiers in medicine·2025
Same author

Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2025
Same author

Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxycycline Postexposure Prophylaxis-Eligible Population.

The Journal of infectious diseases·2024
Same author

Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIV.

JACC. Advances·2024
Same author

<i>Staphylococcus aureus</i> Tetracycline Resistance and Co-resistance in a Doxy-PEP-Eligible Population.

medRxiv : the preprint server for health sciences·2024

Related Experiment Video

Updated: Jun 16, 2026

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

Predicting virologic failure in an HIV clinic.

Gregory K Robbins1, Kristin L Johnson, Yuchiao Chang

  • 1Harvard Medical School, Boston, Massachusetts, USA. grobbins@partners.org

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|February 4, 2010
PubMed
Summary

A new risk score using electronic health record data can predict human immunodeficiency virus (HIV) virologic failure. This tool helps identify patients needing targeted interventions for better HIV treatment outcomes.

More Related Videos

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Related Experiment Videos

Last Updated: Jun 16, 2026

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage (Tropism) by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Area of Science:

  • Medical Informatics
  • Virology
  • Public Health

Background:

  • Electronic health records (EHRs) offer valuable data for predicting patient outcomes.
  • Predicting virologic failure in human immunodeficiency virus (HIV) patients is crucial for effective treatment.

Purpose of the Study:

  • To develop and validate a prediction rule for virologic failure in HIV-infected patients using EHR data.
  • To create a simplified clinical prediction rule for practical application.

Main Methods:

  • Utilized EHR data from two tertiary care hospitals in Boston.
  • Developed a multivariable logistic model to derive a 1-year virologic failure prediction rule.
  • Validated the model and simplified it into a clinical prediction rule.

Main Results:

  • The prediction model demonstrated good discrimination (C statistic, 0.78-0.79) and calibration.
  • A 7-variable clinical prediction rule was developed, including adherence, CD4 count, substance abuse, ART experience, missed appointments, prior failure, and duration of suppression.
  • This rule stratified patients into low-, medium-, and high-risk groups with distinct 1-year virologic failure rates (3.0%, 13.0%, 28.6%).

Conclusions:

  • A risk score derived from EHR data effectively predicts 1-year HIV virologic failure.
  • The clinical prediction rule can identify patients at high risk for virologic failure.
  • This tool can guide targeted interventions to improve HIV treatment outcomes.